Hidradenitis Suppurativa Responds Quickly to Novel BTK Inhibitor

(MedPage Today) -- SAN DIEGO -- An investigational Bruton's tyrosine kinase (BTK) inhibitor significantly improved hidradenitis suppurativa (HS) disease status in a randomized, placebo-controlled trial reported here. More than 70% of patients...
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news